• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经导管动脉栓塞术后残留肝细胞癌中血管内皮细胞和肿瘤细胞增殖活性增加。

Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization.

作者信息

Kim Y B, Park Y N, Park C

机构信息

Department of Pathology, Ajou University School of Medicine, Suwon, Korea.

出版信息

Histopathology. 2001 Feb;38(2):160-6. doi: 10.1046/j.1365-2559.2001.01064.x.

DOI:10.1046/j.1365-2559.2001.01064.x
PMID:11207829
Abstract

AIMS

Transcatheter arterial embolization induces extensive ischaemic necrosis or hypoxia via the obstruction of the hepatic artery in hepatocellular carcinoma (HCC). Ischaemia is strongly correlated with an increased expression of angiogenic factor and stimulates an increase in angiogenesis, including endothelial cell proliferation. The aim of this study was to evaluate whether ischaemic necrosis induced by transcatheter arterial embolization could increase the proliferative activities of intratumoral endothelial cells or tumour cells in the residual HCC.

METHODS AND RESULTS

Using a double immunohistochemical technique (Ki67 antibody to determine the proliferative activity and CD34 antibody to highlight the intratumoral endothelial cells), we performed immunohistochemical staining for 24 HCCs treated by transcatheter arterial embolization. Seven HCCs without any preoperative transcatheter arterial embolization and nine cirrhosis cases were also studied as the control cases. The residual tumour was then divided into five areas at 0.5 mm intervals, according to the distance from the necrotic margin induced by embolization. The Ki67 labelling indices of the intratumoral endothelial cells and tumour cells were counted in each area. The correlation between the indices and the corresponding distance from the ischaemic necrosis was analysed. The Ki67 labelling index of intratumoral vascular endothelial cells in the area less than 0.5 mm from the necrotic margin (area 1) was 10.60 +/- 3.64% (mean +/- SD), which was twofold greater than those of the other areas more than 0.5 mm from the margin (areas 2--5) and those of the control HCCs without preoperative transcatheter arterial embolization. In addition, the proliferation labelling index of the tumour cells was 35.77 +/- 11.45% (mean +/- SD) in area 1. This was higher than those of areas 2--5 and control HCCs without preoperative transcatheter arterial embolization. There was a positive correlation between the proliferation of both endothelial and tumour cells and ischaemic necrosis (P < 0.05).

CONCLUSIONS

Our study suggests that the proliferative activity of intratumoral endothelial cells and tumour cells is increased by ischaemic necrosis induced by transcatheter arterial embolization, and its effect is maximal in the area adjacent to the necrosis (less than 0.5 mm from the necrotic margin).

摘要

目的

经导管动脉栓塞术通过阻塞肝细胞癌(HCC)的肝动脉诱导广泛的缺血性坏死或缺氧。缺血与血管生成因子表达增加密切相关,并刺激血管生成增加,包括内皮细胞增殖。本研究的目的是评估经导管动脉栓塞术诱导的缺血性坏死是否会增加残余HCC中肿瘤内内皮细胞或肿瘤细胞的增殖活性。

方法与结果

采用双重免疫组织化学技术(用Ki67抗体确定增殖活性,用CD34抗体突出肿瘤内内皮细胞),对24例行经导管动脉栓塞术治疗的HCC进行免疫组织化学染色。7例未行任何术前经导管动脉栓塞术的HCC和9例肝硬化病例也作为对照病例进行研究。然后根据距栓塞诱导的坏死边缘的距离,将残余肿瘤以0.5毫米的间隔分为五个区域。在每个区域计数肿瘤内内皮细胞和肿瘤细胞的Ki67标记指数。分析指数与距缺血性坏死相应距离之间的相关性。距坏死边缘小于0.5毫米的区域(区域1)内肿瘤血管内皮细胞的Ki67标记指数为10.60±3.64%(平均值±标准差),是距边缘大于0.5毫米的其他区域(区域2-5)以及未行术前经导管动脉栓塞术的对照HCC的两倍。此外,区域1内肿瘤细胞的增殖标记指数为35.77±11.45%(平均值±标准差)。这高于区域2-5以及未行术前经导管动脉栓塞术的对照HCC。内皮细胞和肿瘤细胞的增殖与缺血性坏死之间存在正相关(P<0.05)。

结论

我们的研究表明,经导管动脉栓塞术诱导的缺血性坏死会增加肿瘤内内皮细胞和肿瘤细胞的增殖活性,且在与坏死相邻的区域(距坏死边缘小于0.5毫米)效果最大。

相似文献

1
Increased proliferation activities of vascular endothelial cells and tumour cells in residual hepatocellular carcinoma following transcatheter arterial embolization.经导管动脉栓塞术后残留肝细胞癌中血管内皮细胞和肿瘤细胞增殖活性增加。
Histopathology. 2001 Feb;38(2):160-6. doi: 10.1046/j.1365-2559.2001.01064.x.
2
Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected cases.经导管肝动脉栓塞术后的肝细胞癌。84例切除病例的组织病理学研究。
Cancer. 1994 May 1;73(9):2259-67. doi: 10.1002/1097-0142(19940501)73:9<2259::aid-cncr2820730905>3.0.co;2-p.
3
Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization.经导管动脉化疗栓塞术后肝细胞癌中血管内皮生长因子表达增加。
Acta Radiol. 2008 Jun;49(5):523-9. doi: 10.1080/02841850801958890.
4
Response of early-stage hepatocellular carcinoma and borderline lesions to therapeutic arterial embolization.早期肝细胞癌及临界病变对治疗性动脉栓塞的反应
AJR Am J Roentgenol. 1993 Feb;160(2):301-6. doi: 10.2214/ajr.160.2.8380949.
5
Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.经导管动脉栓塞或化疗栓塞后标准化兔模型中的肝细胞坏死、凋亡和增殖。
J Vasc Interv Radiol. 2011 Nov;22(11):1606-12. doi: 10.1016/j.jvir.2011.08.005. Epub 2011 Sep 29.
6
Resection of hepatocellular carcinoma after transcatheter arterial embolization. Reevaluation of the advantages and disadvantages of preoperative embolization.
Arch Surg. 1987 Jul;122(7):756-9. doi: 10.1001/archsurg.1987.01400190022004.
7
Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.经导管肝动脉栓塞联合瘤内注射树突状细胞治疗肝细胞癌的临床安全性
Clin Exp Immunol. 2007 Feb;147(2):296-305. doi: 10.1111/j.1365-2249.2006.03290.x.
8
Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.乳腺癌中瘤内内皮细胞增殖与微血管密度(肿瘤血管生成)及肿瘤细胞增殖的相关性。
Am J Pathol. 1994 Jun;144(6):1188-94.
9
Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.经皮米托蒽醌注射、经皮乙醇注射及经导管动脉栓塞联合治疗肝内肝细胞癌及肾上腺转移瘤
Hepatogastroenterology. 2001 Mar-Apr;48(38):427-31.
10
[Histopathologic study on resected hepatocellular carcinoma after transcatheter hepatic arterial chemo-embolization].经导管肝动脉化疗栓塞术后切除肝细胞癌的组织病理学研究
Zhonghua Yi Xue Za Zhi. 1991 Jul;71(7):366-8, 26.

引用本文的文献

1
A Lipiodol Pickering Emulsion Stabilized by Iron-Doped Carbon Nanozymes for Liver Transarterial Chemoembolization.一种由铁掺杂碳纳米酶稳定的碘油皮克林乳液用于肝动脉化疗栓塞术
Adv Sci (Weinh). 2025 Feb;12(5):e2410873. doi: 10.1002/advs.202410873. Epub 2024 Dec 10.
2
Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies.血管生成与肝细胞癌:从分子机制到系统治疗。
Medicina (Kaunas). 2023 Jun 9;59(6):1115. doi: 10.3390/medicina59061115.
3
Intravoxel incoherent motion imaging used to assess tumor microvascular changes after transarterial chemoembolization in a rabbit VX2 liver tumor model.
在兔VX2肝癌模型中,采用体素内不相干运动成像评估经动脉化疗栓塞术后肿瘤微血管变化。
Front Oncol. 2023 Feb 28;13:1114406. doi: 10.3389/fonc.2023.1114406. eCollection 2023.
4
Donafenib-Loaded Callispheres Beads Embolization in a VX2 Liver Tumor: Investigating Efficacy, Safety, and Improvement of Tumor Angiogenesis After Embolization.载多纳非尼的碘油微球栓塞治疗VX2肝癌:栓塞术后疗效、安全性及肿瘤血管生成改善情况的研究
J Hepatocell Carcinoma. 2021 Dec 3;8:1525-1535. doi: 10.2147/JHC.S337097. eCollection 2021.
5
Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma.载药微球粒径和载药量对肝癌大鼠经肝动脉化疗栓塞后肿瘤细胞损伤的影响。
Nanomedicine. 2022 Jan;39:102465. doi: 10.1016/j.nano.2021.102465. Epub 2021 Sep 24.
6
Anti-Angiogenic Therapy: Albumin-Binding Proteins Could Mediate Mechanisms Underlying the Accumulation of Small Molecule Receptor Tyrosine Kinase Inhibitors in Normal Tissues with Potential Harmful Effects on Health.抗血管生成疗法:白蛋白结合蛋白可能介导小分子受体酪氨酸激酶抑制剂在正常组织中蓄积的潜在健康有害机制。
Diseases. 2021 Apr 10;9(2):28. doi: 10.3390/diseases9020028.
7
Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment response.一种缺氧相关特征增强了对肝细胞癌患者预后的预测,并与索拉非尼治疗反应相关。
Am J Transl Res. 2020 Dec 15;12(12):7762-7781. eCollection 2020.
8
Management of patients with intermediate stage hepatocellular carcinoma.中期肝细胞癌患者的管理
Ther Adv Med Oncol. 2020 Nov 5;12:1758835920970840. doi: 10.1177/1758835920970840. eCollection 2020.
9
Rational design of temperature-sensitive blood-vessel-embolic nanogels for improving hypoxic tumor microenvironment after transcatheter arterial embolization.理性设计温度敏感型血管栓塞纳米凝胶以改善经导管动脉栓塞后缺氧肿瘤微环境。
Theranostics. 2018 Nov 29;8(22):6291-6306. doi: 10.7150/thno.28845. eCollection 2018.
10
Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply.肝细胞癌治疗中针对脉管系统:饿死与使血液供应正常化。
Clin Transl Gastroenterol. 2017 Jun 15;8(6):e98. doi: 10.1038/ctg.2017.28.